Glucose-insulin-potassium solution for acute myocardial infarction

Annals of Pharmacotherapy

Volumn 36, Issue 6, 2002, Pages 1080-1084

  Janiger, Jeffrey L ^a   Cheng, Judy W M ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Glucose; Insulin; Myocardial infarction; Potassium

Indexed keywords

GLUCOSE DERIVATIVE; GLUCOSE INSULIN POTASSIUM SOLUTION; INSULIN; POTASSIUM CHLORIDE; UNCLASSIFIED DRUG; GLUCOSE; GLUCOSE INSULIN POTASSIUM CARDIOPLEGIC SOLUTION; GLUCOSE-INSULIN-POTASSIUM CARDIOPLEGIC SOLUTION; POTASSIUM;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL TRIAL; HEART PROTECTION; HUMAN; MEDLINE; META ANALYSIS; MORALITY; MORBIDITY; MULTICENTER STUDY; PRIORITY JOURNAL; DRUG COMBINATION; DRUG CONTRAINDICATION; HEART INFARCTION; MORTALITY; REVIEW;

CLINICAL TRIALS; DRUG COMBINATIONS; GLUCOSE; HUMANS; INSULIN; MYOCARDIAL INFARCTION; POTASSIUM;

EID: 0036014081     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A300     Document Type: Article

References (14)

1. Effects of an intravenous infusion of a potassium-insulin-glucose solution on electrocardiographic signs of myocardial infarction
2. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: An overview of randomized placebo-controlled trials
3. Metabolic modulation of acute myocardial infarction: The ECLA glucose-insulin-potassium pilot trial
4. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: Results of a randomized multicenter Pol-GIK trial
5. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias
6. Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction
7. Effects of infusion of glucose-insulin-potassium on myocardial function after a recent myocardial infarction
8. Glucose-insulin-potassium in acute myocardial infarction
9. Glucose delivery is a major determinant of glycose utilization in the ischemic myocardium with a residual coronary flow
10. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions
11. Outcomes of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents
12. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects are mortality at 1 year
13. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction